Another company, Saluda Medical, already has FDA approval ... they expect to “revolutionize” the market. The use of ...
Hosted on MSN1mon
Saluda Medical secures $100m for Evoke System commercialisationSaluda Medical has completed a $100m financing ... The platform claims to operate by delivering spinal cord stimulation (SCS) therapy that senses and measures neural activation, with an aim ...
MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical ... of objective neurophysiological measurements in spinal cord stimulation (SCS) with evoked compound action potential (ECAP) dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results